Stratistics Market Research Consulting

Prostate Cancer Therapeutics Market Report 2017, Trends, Analysis, Share, Estimates and Forecasts to 2022.

Press Release   •   Aug 01, 2017 22:49 EDT

According to Stratistics MRC, the Global Prostate Cancer Therapeutics market is estimated at $XX million in 2016 and is expected to reach $XX million by 2023 growing at a CAGR of XX% from 2016 to 2023. Increase in prostate cancer cases in recent years and raise in development of innovative drugs are the some of the prominent factors driving the market growth. Whereas high cost and low success rate in the clinical test are hampering the market. However, increase in geriatric population and increase in R&D expenditure in this market seems to be opportunity for the market growth. In 2016, North America accounted for the highest market share owing to increase in research and development expenditure. The Asia Pacific region is expected to grow at a higher CAGR and is anticipated to account for the highest market share during forecast period because of government initiatives on creating awareness on prostate cancer.

Some of the key players in the market include Tolmar Inc, Teva Pharmaceutical Industries Ltd, Takeda Pharmaceutical Co. Ltd, Sanofi-Aventis, Pfizer Inc, Johnson & Johnson, Ipsen, Ferring Pharmaceuticals, Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc), Dendreon Corporation, Bristol-Myers Squibb, Astrazeneca Plc, Astellas Pharma Inc, Active Biotech and Abbott Laboratories.

For More, Please Visit:

Drugs Classes Covered:
• Chemotherapy
o Estramustine (Emcyt)
o Mitoxantrone (Novantrone)
o Jevtana
o Taxotere
• Targeted Therapy
o Xofigo
• Hormonal Therapy
o Anti-Androgens
o Luteinizing Hormone-Releasing Hormone (LHRH) Antagonists
o Luteinizing Hormone-Releasing Hormone (LHRH) Analogs
• Immunotherapy
o Provenge

Distribution Channels Covered:
• Hospital Pharmacy
• Retail Pharmacy
• Online Sales
• Other Distribution Channels

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

For More, Please Visit:

We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends. Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.